跳轉至內容
Merck
全部照片(2)

重要文件

268569

Sigma-Aldrich

三甲基铝 溶液

2.0 M in hexanes

同義詞:

Trimethylalane

登入查看組織和合約定價


About This Item

線性公式:
(CH3)3Al
CAS號碼:
分子量::
72.09
Beilstein:
3587197
MDL號碼:
分類程式碼代碼:
12352103
PubChem物質ID:
NACRES:
NA.22

形狀

liquid

品質等級

濃度

2.0 M in hexanes

密度

0.683 g/mL at 25 °C

SMILES 字串

C[Al](C)C

InChI

1S/3CH3.Al/h3*1H3;

InChI 密鑰

JLTRXTDYQLMHGR-UHFFFAOYSA-N

尋找類似的產品? 前往 產品比較指南

一般說明

Trimethylaluminum is a Lewis acid having wide applications in organic synthesis. It is employed in organic reactions like cross-coupling reaction, methylenation, carboalumination, cyclopropanation, and rearrangement reactions. Tebbe Reagent (methylenation agent) can be prepared in situ by reacting trimethylaluminum with dichlorobis(cyclopentadienyl)titanium.

應用

与 4-溴-2,6-二叔丁基苯酚(货号394378)一起用于通过环氧化物的选择性重排制备各种羰基化合物。

訊號詞

Danger

危險分類

Aquatic Chronic 2 - Asp. Tox. 1 - Eye Dam. 1 - Flam. Liq. 2 - Pyr. Liq. 1 - Repr. 2 - Skin Corr. 1B - STOT SE 3 - Water-react 1

標靶器官

Central nervous system

安全危害

儲存類別代碼

4.2 - Pyrophoric and self-heating hazardous materials

水污染物質分類(WGK)

WGK 3

閃點(°F)

-0.4 °F - closed cup

閃點(°C)

-18 °C - closed cup


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Tetrahedron, 47, 6983-6983 (1991)
Tetrahedron Letters, 30, 5607-5607 (1989)
Mahtab Farzin et al.
Pathology, 47(4), 302-307 (2015-05-06)
BRCA1-associated protein 1 (BAP1) is a tumour suppressor gene frequently inactivated in mesothelioma, rarely also in association with germline mutation. BAP1 mutations have been associated with improved prognosis and distinct clinicopathological features. We sought to determine the clinicopathological significance of
Alexander C Kozen et al.
ACS nano, 9(6), 5884-5892 (2015-05-15)
Lithium metal is considered to be the most promising anode for next-generation batteries due to its high energy density of 3840 mAh g(-1). However, the extreme reactivity of the Li surface can induce parasitic reactions with solvents, contamination, and shuttled
J L L Robinson et al.
Oncogene, 33(50), 5666-5674 (2013-12-03)
Castration-resistant prostate cancer (CRPC) continues to pose a significant clinical challenge with new generation second-line hormonal therapies affording limited improvement in disease outcome. As the androgen receptor (AR) remains a critical driver in CRPC, understanding the determinants of its transcriptional

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務